Clinical trial Recruiting at 1 site Observational Ages 18 and up

Understanding immune profiles in healthy and diseased lungs

Official title: Study of Inflammatory and Physiological Profiles of Healthy and Diseased Lung

Run by Guy's and St Thomas' NHS Foundation Trust · NCT06144476 · Data updated 2026-11-12

This study is trying to understand how the immune system works in healthy lungs compared to those with airway diseases like COPD and asthma by looking at samples from both groups.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment230 (estimated)
SponsorGuy's and St Thomas' NHS Foundation Trust
Academic / other
Locations1 site (London, London)
StatusRecruiting
StartedFebruary 8, 2024
Main results expectedAugust 31, 2026
Study endsAugust 31, 2029
Registry record updatedJune 4, 2026
Trial IDNCT06144476 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults over 18 with diagnosed or suspected airway diseases like COPD or asthma, as well as healthy individuals without significant illness.

Probably not a fit

Patients with known or suspected pulmonary infections, significant comorbidities, or those unable to provide informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the immunopathology of airway diseases such as COPD and asthma by analyzing matched samples from the respiratory tract and circulation. Participants over 18 years old with diagnosed or suspected airway disease, as well as healthy volunteers, will be enrolled. The study will involve various assessments including lung function tests, sputum collection, and optional bronchoscopy visits to gather detailed immune response data. Participants will be monitored yearly and during clinically relevant events to track changes in their condition.

Why it matters

Potential benefit: If successful, this study could lead to a better understanding of lung diseases and improved treatment strategies for patients with airway diseases.

How similar studies have gone: While similar studies have explored immune profiles in lung diseases, this specific approach of matched sample analysis is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participant is willing and able to give informed consent for participation in the study
* Aged 18 years or above
* Patient: known or suspected airway disease
* Healthy volunteer: considered to be in good health with no significant comorbidity (immune disorder, cancer etc.)

Exclusion Criteria:

* Known or suspected current pulmonary tuberculosis, HIV (human immunodeficiency virus), Hepatitis B Virus, Hepatitis C Virus.
* Surgery within the preceding 6 weeks
* Participants who are pregnant
* History of psychiatric, medical, or surgical disorders that in the opinion of the chief investigator may interfere with sample collection, undergo a bronchoscopy, or may compromise study completion or data collection
* Alcohol or recreational drug abuse
* Diagnosis of immunodeficiency requiring treatment
* Unable to provide written informed consent
* Unable to read or write English
* Be considered, in the opinion of the investigator, to be an unsuitable candidate for the study

Where it's running

  • Guy's & St Thomas' NHS Foundation Trust
    London, London, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.